Key Takeaways
- DSO partnership offers typically combine cash at close, retained equity, and earnouts. Sellers benefit from evaluating each component separately instead of relying on headline enterprise value.
- Four primary partnership models exist: doctor-owned, PE-backed, specialty-focused, and joint-venture. Each model carries distinct implications for clinical autonomy, equity structure, and post-close governance.
- A significant portion of DSO consideration is often paid in equity, so sellers can benefit from vetting platforms like investments by examining profitability, leadership track record, sponsor hold periods, and doctor retention.
- Size rankings mislead sellers; a structured, competitive bid process across vetted buyers is what moves valuation, not the length of a platform’s practice list.
- McLerran & Associates delivers dental-only, sell-side representation with CPA-led EBITDA valuations that let owners compare DSO offers side by side.
Schedule A Discovery Call with McLerran & Associates
What “Top DSOs For Dental Partnership” Really Means For A Seller
A DSO partnership is an affiliation in which a practice owner sells all or part of the practice to a dental service organization. The owner typically receives cash at close plus retained equity and an earnout, and often continues to practice under a working agreement.
“Top” should mean best fit and best terms for the seller, which is a different question from practice count. The ADA Health Policy Institute reports that 16% of U.S. dentists were affiliated with a DSO in 2024, up from 8.8% in 2017, and the market now spans dozens of models with meaningfully different ownership structures, equity arrangements, and post-close environments. Size rankings answer “who is biggest” and leave the terms that determine proceeds and autonomy unaddressed. The sections that follow walk through models, payouts, diligence signals, and specialty fit so an owner can apply them to their specific practice.
The Partnership Models Behind Top DSOs And Who Each Fits
The DSO market organizes itself into four broad models. Each model affects decision rights, clinical autonomy, equity type, growth capital, and post-close support in different ways.
Doctor-owned and doctor-partnership models are built around dentist equity and governance. The affiliated doctor retains an ownership interest, sometimes at the practice level and sometimes in the broader platform, and participates in distributions and future value creation. Some organizations in this category brand themselves as dental partnership organizations (DPOs) and structure affiliation as a partnership in which practice owners retain autonomy and equity rather than a conventional management-services arrangement. These models can suit owners who want to stay entrepreneurially engaged and share in platform upside. Governance rights attached to retained equity vary widely and deserve careful review.
PE-backed platform models are the most common structure in today’s market. These platforms provide scale, capital, and infrastructure, and the seller becomes a minority equity holder in an organization whose exit timeline is set by the sponsor. Diligence on the sponsor’s remaining hold period, debt structure, and recapitalization plan can be some of the main factors in evaluating this path.
Specialty-focused groups concentrate on one or two specialties such as oral and maxillofacial surgery, orthodontics, pediatric dentistry, or endodontics. These buyers can offer specialty-specific clinical leadership, referral infrastructure, and recruiting capability that a general-practice platform may not credibly provide. For a specialist, the key question is whether the platform’s operating model supports the specialty’s workflow or simply bolts specialty practices onto a general-practice infrastructure.
Joint-venture and autonomy models allow the selling doctor to retain a meaningful ownership stake at the practice level, often 20% to 49%, while the DSO holds the majority interest. In one documented JV structure, roughly 55% of a $1 million practice’s value is paid as cash at close, about 15% is rolled into parent-company equity, and the doctor retains 30% of the practice under a five-year partnership arrangement. JV models can preserve clinical decision-making because the doctor holds a meaningful economic stake. The distributions, voting rights, transfer restrictions, and exit provisions attached to that stake are defined in the governing documents rather than in the marketing materials.
McLerran & Associates evaluates every model rather than steering owners into one lane. Model choice often drives the terms an owner lives with for years after close more than brand size does.
How DSO Partnerships Pay: Cash, Equity, And Earnouts
Most DSO deals combine several payment types instead of paying all cash at closing. A typical offer includes cash at close, retained equity, an earnout tied to post-closing metrics, and a multi-year employment or professional-services arrangement. Reviewing each component separately gives a clearer comparison between term sheets.
Cash at close is the most certain and liquid portion of the consideration. Many DSOs are offering deals with 60% to 85% of total consideration paid as cash at close, with the remainder potentially consisting of equity, earnouts, rollover investment, or other contingent consideration. The headline enterprise value rarely equals cash proceeds.
Equity can be held at two distinct levels, and the difference matters. JV-level equity is an interest in the local practice or joint venture. It typically carries distributions, which gives it a higher floor but a lower ceiling, because its value is tied to that specific practice’s performance. Holding-company equity is a rollover interest in the broader platform. It carries no distributions but a potentially higher ceiling if the platform is later sold at a higher multiple. Between 30% and 45% of a typical dental DSO transaction is likely to come in the form of rollover equity rather than cash at close, split between JV equity and holding-company equity. Because as much as ~40% of a deal can be paid in equity, the owner is effectively an investor and can benefit from underwriting the DSO accordingly.
Earnouts make a portion of the consideration contingent on post-closing performance metrics such as revenue, production, or EBITDA. EBITDA means earnings before interest, taxes, depreciation, and amortization, and it is a common measure of operating profitability. Because the DSO controls operations, staffing, and marketing after closing, sellers can benefit from scrutinizing the specific benchmarks, measurement periods, and dispute resolution mechanisms before agreeing. Non-punitive structures, such as pro-rata provisions that pay most of the earnout even on a near-miss or later start dates that account for integration, are worth negotiating specifically.
McLerran & Associates produces multi-year, multi-structure financial forecasting that models what each deal structure can net the owner over 3-, 5-, 7-, and 10-year horizons, including conservative recapitalization assumptions. This content is education, not tax or investment advice, and owners should consult their own CPA and legal counsel before signing any letter of intent.
A deeper review of the specific DSO deal terms dentists should know and negotiate is available here.
How To Vet A DSO’s Financial Strength And Post-Close Track Record
A meaningful share of many DSO deals is paid in equity, so the platform’s health can affect a large portion of the owner’s proceeds. Vetting a DSO like an investment belongs at the center of the seller’s due diligence.
Market-level signals worth examining include:
- Whether the whole company is profitable and whether revenue is growing at offices it already owns, not just at newly acquired locations
- Whether leadership is experienced and has completed this kind of transaction successfully before
- Whether the financial backer has a documented track record of exits from healthcare investments and sufficient follow-on capital
- What former partner-dentists say about the post-close environment, clinical autonomy, and whether the DSO delivered on its stated commitments
- The sponsor’s remaining hold period, debt maturity dates, and refinancing needs, since more than 20 PE-backed dental platforms were seven or more years into their hold periods as of 2026, which can set up recapitalizations that affect retained equity value
- Doctor retention and tenure, since how long doctors have been with the organization and how embedded they are in their communities can signal stability
McLerran & Associates vets buyers like investments, which means poorly run DSOs never make it into the process at all. That screening is what steers owners toward well-backed partners with a track record of happy sellers and away from platforms that emerged during the low-interest-rate expansion without building genuine operational value.
A full framework for vetting DSO partners before selling is available here.
Have Your Next DSO Offer Vetted Before You Sign
Specialty Fit Among Top DSOs For Dental Partnership
Vetting the platform is only half the diligence. The other half is knowing which buyers are actually competing for your specialty, because a practice’s specialty shapes buyer demand, the pool of interested DSOs, and the terms those buyers are willing to offer. Specialty can be the single largest determinant of which model fits and what the market will pay.
Oral and maxillofacial surgery was the only dental specialty that did not see a decline in private-equity deal activity in the prior year, instead posting a 9.1% increase, which makes it the fastest-consolidating segment and the one currently commanding the highest multiples. Specialty-focused platforms in this space often use joint-venture structures rather than outright acquisitions, preserving some practice-level ownership for the selling surgeon.
Pediatric dentistry is drawing intense DSO attention, driven by lower operating costs, predictable hygiene revenue, and multigenerational patient relationships that feed referrals across a platform. Orthodontics attracts a different kind of buyer, one that understands the longer patient journey, treatment coordinator infrastructure, and referral network dynamics specific to that specialty. In both cases, the buyer’s operating model has to match the specialty’s workflow, not just its revenue profile.
General dentistry continues to earn aggressive, near-all-time-high valuations from a broad pool of buyers. The market for premier general practices remains competitive, and owners in this category have the widest range of model options, from doctor-partnership structures to large PE-backed platforms to joint-venture arrangements.
Lighter-demand specialties such as prosthodontics sit at the lower end of buyer interest and valuation ranges. For these owners, the private-buyer path may be as competitive as, or more competitive than, the DSO path. A side-by-side valuation across both markets can be valuable before committing to either.
McLerran & Associates reads specialty-by-specialty dynamics rather than treating every practice the same. Its dental-only focus means it understands which buyers are actively competing for each specialty in each region right now.
Why Size Rankings Mislead And How To Create Competition
Size-ranked rosters of large national platforms answer one question: who has the most practices. They answer a question no seller is actually asking and leave the terms that determine proceeds entirely unaddressed. More importantly, they expose the seller to a single buyer, or a short list of familiar names, instead of the full competitive market.
A seller who negotiates directly with one DSO has limited leverage. The DSO knows it is the only bidder. There is no competitive tension to push the price up, no alternative to walk toward if the terms deteriorate during diligence, and no way to know whether the offer is at market or well below it. Sale preparation and marketing processes often produce offers differing by 40% or more, usually with a significant increase from initial to final offers.
The alternative is a structured, auction-like process among vetted buyers. McLerran & Associates typically runs a ~45–60-day bid process that generates around 10 offers per listing. Clients typically see the valuation lift described in the takeaways and see the real market rather than a single suitor’s opening position.
That leverage only works if the advisor is on your side of the table, which is why McLerran & Associates is sell-side only and represents the owner, never the buyer. Its incentives are fully aligned with the seller at every stage of the process. A framework for comparing dental partnership deals side by side is available here.
Start A Confidential Conversation
Conclusion And Next Steps
The evaluation method often matters more than any ranking. Segment by partnership model, map each to its payout structure, vet the DSO like an investment, and run a competitive process across vetted buyers. McLerran & Associates is built around exactly that sequence, with a dental-only, sell-side-only focus and a CPA-led, diligence-grade EBITDA valuation that lets owners compare offers side by side.
Owners who are ready to understand what their practice is worth in both markets, and what a competitive process could look like for their specific situation, can contact McLerran & Associates at (512) 900-7989, by email at info@dentaltransitions.com, or through the contact form below. Owners who are not yet ready to decide may benefit from the McLerran M&A Summit, scheduled for October 29–30, 2026, in Austin, a dental-only event that awards 4 CE credits and includes a complimentary $2,500 practice valuation for attendees.
See What Your Practice Is Worth in Both Markets
Frequently Asked Questions
What Is A DSO Partnership?
A DSO partnership is an affiliation in which a practice owner sells all or part of their practice to a dental service organization. The seller typically receives cash at close, retained equity in the practice or the broader platform, and sometimes an earnout tied to future performance metrics. Most DSO deals also include a multi-year working agreement under which the selling dentist continues to practice. The specific structure, including how much is cash, what type of equity is retained, and what the earnout requires, varies significantly from deal to deal and from model to model.
Which DSO Partnership Model Fits A Practice My Size?
Model fit depends on practice size, specialty, and the owner’s goals. Practices generating roughly $1 million to $1.5 million in annual revenue often fit a doctor-to-doctor sale. The $1.5–3 million middle can pursue either path. For that group, a side-by-side valuation across both is the most reliable way to compare them. Above roughly $3 million, practices are the typical candidates for DSO or private-equity affiliation, with options ranging from doctor-partnership structures to PE-backed platforms to joint-venture arrangements. The largest practices, particularly those with multiple locations and strong EBITDA, can sometimes become the platform acquisition for a new DSO, with the owner stepping into a leadership role. Specialty also shapes fit, since oral surgery, orthodontics, and pediatric dentistry attract specialty-focused buyers with distinct model preferences.
Are DSO Deals All Cash, Or Is There Stock Involved?
Most DSO deals use a mix of payment types. A typical DSO offer combines cash at close, equity, and an earnout. Equity can be held at the joint-venture level, tied to the specific practice with distributions but a lower ceiling, or at the holding-company level, tied to the broader platform with a potentially higher ceiling but no distributions until a recapitalization or sale. As noted earlier, equity can account for a large share of total consideration, which means the owner is effectively an investor in the DSO and should evaluate the platform’s financial strength, debt structure, and exit timeline before agreeing to any equity component. Sellers should consult a CPA before signing a letter of intent, since the tax treatment of each component differs.
Do I Have To Keep Working After A DSO Partnership?
On a DSO deal, a minimum working agreement is standard, typically around five years. The length and terms of that commitment affect the total economic value of the deal, since compensation during the work-back period is usually structured as a percentage of collections rather than at the owner’s prior income level. On a private doctor-to-doctor walk-away sale, the work-back is typically much shorter, around four to eight weeks, before the seller exits. Owners who have already reduced their clinical hours may be able to negotiate a shorter post-close commitment in a DSO deal, but this depends on the buyer and the practice’s associate base.
How Do I Know Which DSOs Are Well Run?
Evaluating whether a DSO is well run requires looking beyond its marketing materials. Key signals include whether the whole company is profitable and growing at practices it already owns, whether leadership has a documented track record of successful exits from healthcare investments, whether the financial backer has sufficient follow-on capital and a reasonable remaining hold period, and what former partner-dentists say about the post-close environment. Doctor retention and tenure are meaningful stability indicators. Debt structure, maturity dates, and refinancing needs matter because a DSO under financial pressure may not deliver on the infrastructure and growth support it promised. McLerran & Associates vets buyers like investments and has blacklisted DSOs known for poor post-close environments, so owners who engage the firm are steered toward well-backed, well-run partners from the outset.
